Trial
NCT05781451
Anti-BTLA Agonist Therapy in Subjects With Primary Sjogren's Syndrome
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Stanford University
Collaborators
—
Condition
Primary Sjogren's Syndrome
Intervention
LY3361237
Why stopped
Drug unavailable
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-17